CDC Influenza Branch Chief to Chair Options for the Control of Influenza VI International Conference

Sep 13, 2005, 01:00 ET from Secretariat, Options for the Control of Influenza VI

    VALLETTA, Malta, September 13 /PRNewswire/ -- The sponsors of the world's
 largest influenza conference are delighted to announce that Dr Nancy J Cox,
 Chief of the Influenza Branch at Centers for Disease Control and Prevention
 (CDC) will Chair the Options for the Control of Influenza VI International
 Conference in Toronto, Canada, June 17-23, 2007.
     Dr Cox, who is also Director of the World Health Organization (WHO)
 Collaborating Center for Epidemiology and Control of Influenza, notes that
 influenza presents formidable challenges for global healthcare and research:
 "Influenza exacts an enormous toll in terms of its morbidity, mortality, and
 economic burden." The Options VI meeting will provide state-of-the-art
 scientific information on prevention, control and treatment of influenza,
 including seasonal and pandemic planning.
     The Options VI meeting will be sponsored by the newly formed
 International Society for Influenza and other Respiratory Virus Diseases
 (isirv). This important new society, founded at The Second European Influenza
 Conference on September 11, 2005, is the first scientifically independent
 professional body to represent the full spectrum of activity in its field,
 from basic science to healthcare policy. It will work for the prevention,
 detection, treatment and control of influenza and other respiratory viral
 diseases throughout the world. Membership will be open to scientists,
 clinicians, public health experts and others with a professional interest in
 respiratory viruses.
     The launch of isirv is welcomed by offices of the WHO, the WHO
 Collaborating Centres for Reference and Research on Influenza, and an
 international group of individual scientists, clinicians and public health
 experts. It comes at a crucial point in time as recent outbreaks of a highly
 virulent avian influenza virus combined with evidence of transmission from
 poultry to man are increasing concerns regarding a potential influenza
 pandemic. For many countries, preparing for the next influenza pandemic is a
 major priority. However isirv is also interested in other significant
 respiratory viruses such as Severe Acute Respiratory Syndrome (SARS),
 pneumoviruses and others.
     Chair of isirv, Dr Geoffrey C Schild, states that one of isirv's aims is
 to promote international collaboration between scientists and public health
 specialists against viral respiratory diseases. The Options VI influenza
 meeting will help meet this objective by providing a forum for global
 scientists to exchange and disseminate information to combat this perennially
 challenging adversary.
     Editor's note
     - Additional information: www.optionsviconference.com and www.isirv.org.
 
 

SOURCE Secretariat, Options for the Control of Influenza VI